Search NASA⌕ Search

Engineering topics

Liang, Ling

Publications and source records attributed to Liang, Ling.

Torrefaction of almond shell as a renewable reinforcing agent for plastics: techno-economic analyses and comparison to bioethanol process

Abstract In 2016, the US state of California alone produced nearly 3.5 billion kilograms of almonds, accounting for approximately 84% of the world’s almond production. This generated about 2.58 million metric tons (MTs) of almond residues. Almond shells are currently either burned to generate power or disposed of in landfill. Valorizing almond shells and hulls provides an opportunity to replace petroleum-derived products and divert organic material from landfill. Here we demonstrate a detailed techno-economic analysis (TEA) of an almond shell torrefaction process capable of utilizing the 520 000 MTs of almond shells produced annually in California. Our process also includes preprocessing the torrefied biomass to exploit it as a reinforcing agent for plastics. We further compared the revenue generated from the torrefied biomass and bioethanol derived from the same quantity of almond shells. We considered three different torrefaction facility scales to evaluate trade-offs between economies of scale at the facility and trucking costs to deliver almond shells. A facility that takes in 200 000 MT yr –1 of almond shells results in lower per-unit-output basis capital and operating cost relative to other smaller-scale torrefaction facilities, including 10 000 MT yr –1 and 50 000 MT yr –1 , considered for analysis in this study. The large-sale facility results in a minimum selling price (MSP) of the torrefied biomass of $311.4 MT –1 . An analogous TEA on converting almond residues into bioethanol is also investigated. The MSP of almond shell derived ethanol ($1.71 kg −1 ) is higher than that of corn ($0.48 kg −1 ) or cellulosic biomass ($0.88 kg −1 ) derived ethanol. Compared with the bioethanol route, the torrefied almond shells result in three times more revenue if utilized as a reinforcing agent for plastics.

Liu, Dupeng (ORCID:0000000269514064)↗

Bioprocessing Separations Consortium Three-Year Overview: Technical Advances Process Economics Influence, and State of the Science

The Bioprocessing Separations Consortium solves separations challenges that are unique to bioprocessing. To do this, the Consortium uses two methods: applying existing technologies to new challenges and developing new technologies that may address these unique challenges better than today’s commercial technologies. In its research and development, the Consortium leverages its three core capabilities: materials development and evaluation, process development, and analysis and computation. In its first three years, from 2016 to 2019, the Consortium addressed four critical challenges in biochemical and thermochemical processing. First, the Consortium targeted the fractionation of lignin to enable valorization of this portion of biomass that offers diverse, complex, and valuable building blocks and products. Second, Consortium researchers developed technologies to enable process intensification, which can reduce equipment needs, energy consumption, and waste generation, thereby cutting bioprocessing capital costs and rendering processes more efficient. Third, the Consortium sought to recover carbon from dilute aqueous streams that are common to bioprocessing; recovering dilute carbon can improve process efficiency and economics. Finally, Consortium researchers designed and developed new materials and catalysts to reduce targeted foulants and poisons in bioprocessing streams that can limit the lifetime of downstream catalysts or fermenting microorganisms. Table 1 lists the technologies that were examined and places them in the context of the Consortium’s capabilities, types of bioprocesses, and critical challenges in bioprocessing separations. Overall, across these projects, we have developed separations technologies for 10 bioprocesses, addressed 9 target compounds in bioprocessing, developed 10 materials, and evaluated 4 processes for cost and sustainability.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗

Bioprocessing Separations Consortium: Three-Year Overview - Technical Advances, Process Economics Influence, and State of the Science

The Bioprocessing Separations Consortium solves separations challenges that are unique to bioprocessing. To do this, the Consortium uses two methods: applying existing technologies to new challenges and developing new technologies that may address these unique challenges better than today’s commercial technologies. In its research and development, the Consortium leverages its three core capabilities: materials development and evaluation, process development, and analysis and computation. In its first three years, from 2016 to 2019, the Consortium addressed four critical challenges in biochemical and thermochemical processing. First, the Consortium targeted the fractionation of lignin to enable valorization of this portion of biomass that offers diverse, complex, and valuable building blocks and products. Second, Consortium researchers developed technologies to enable process intensification, which can reduce equipment needs, energy consumption, and waste generation, thereby cutting bioprocessing capital costs and rendering processes more efficient. Third, the Consortium sought to recover carbon from dilute aqueous streams that are common to bioprocessing; recovering dilute carbon can improve process efficiency and economics. Finally, Consortium researchers designed and developed new materials and catalysts to reduce targeted foulants and poisons in bioprocessing streams that can limit the lifetime of downstream catalysts or fermenting microorganisms. Table 1 lists the technologies that were examined and places them in the context of the Consortium’s capabilities, types of bioprocesses, and critical challenges in bioprocessing separations. Overall, across these projects, we have developed separations technologies for 10 bioprocesses, addressed 9 target compounds in bioprocessing, developed 10 materials, and evaluated 4 processes for cost and sustainability.

09 BIOMASS FUELS↗

Methyl Ketones from Municipal Solid Waste Blends by One‐Pot Ionic‐Liquid Pretreatment, Saccharification, and Fermentation

Abstract The conversion of municipal solid waste (MSW) and lignocellulosic biomass blends to methyl ketones (MKs) was investigated by using bioderived ionic liquid (bionic liquid)‐based hydrolysates followed by fermentation with an engineered Escherichia coli strain. The hydrolysates were produced by a one‐pot process using six types of MSW–biomass blends, choline‐based bionic liquids, and commercial enzymes. Based on the sugar yields, one blend (corn stover/MSW=95:5, w / w ) and two bionic liquids {cholinium lysinate ([Ch][Lys]) and cholinium aspartate ([Ch] 2 [Asp])} were selected for scale‐up studies. Maximum yields of 82.3 % glucose and 54.4 % xylose were obtained from the selected blend in the scale‐up studies (6 L), which was comparable with 83.6 % glucose and 52.8 % xylose obtained at a smaller scale (0.2 L). Comparable or higher yields of medium‐chain (C 11 –C 17 ) MKs were achieved by using the MSW–biomass blend‐derived hydrolysates, relative to the sugar controls (glucose and xylose) with similar sugar feeding concentrations. Up to 1145 mg L −1 of MKs was produced by using MSW–biomass‐derived hydrolysates, and the MK titer decreased to 300 mg L −1 when the bionic‐liquid concentration in the hydrolysate increased from 1 to 2 %, indicative of bionic‐liquid inhibition. Technoeconomic analysis was conducted to investigate the economic potential of using the selected MSW–biomass blend as a feedstock to produce MKs.

Yan, Jipeng↗

Structural and biochemical studies of the extracellular domain of Myelin protein zero-like protein 1

Highlights: • Structure of the extracellular domain of human MPZL1 is reported. • MPZL1 shows remarkably truncated strand G than that of its homologous family member MPZ. • Asn50 is a major glycosylation site important for MPZL1 binding ConA. • Dimeric interfaces of MPZL1 are maintained by hydrogen bonds between Ser86 and Val145. Myelin protein zero-like protein 1 (MPZL1) is a member of the immunoglobulin superfamily, and is also a receptor of concanavalin A (ConA). MPZL1 is upregulated in hepatocellular carcinoma (HCC) and accelerates migration of HCC cells. However, function of MPZL1 as a receptor of ConA and its role in HCC development are largely unknown. To elucidate the functional basis, we have determined the crystal structure of the extracellular domain of MPZL1 at 2.7 Å resolution. Overall, it folds like a typical immunoglobulin variable-like domain that is much like MPZ. Unexpectedly, we found Asn50 is a unique glycosylation site and the glycosylation mediates its interaction with ConA. Furthermore, we also found that MPZL1 exists as a homodimer in the crystal, in which hydrogen bonds between Ser86 and Val145 play an important role. Our results demonstrate that glycosylation of Asn50 is essential for its function as a receptor of ConA. We propose that dimerization of MPZL1 participates in control of its signal transmission in cell adhesion.

60 APPLIED LIFE SCIENCES↗

Pilot-Scale Studies of Lignin-Derived Ionic Liquids for Biomass Pretreatment

The polymers found in plant cell walls represent the largest reserves of renewable carbon on Earth - it has been estimated that the United States has approximately 1.3 billion tons of plant biomass available per year. Ionic liquids (ILs) are salts with melting points less than 100oC, typically containing organic cations, that possess a wide range of extraordinary properties as compared to traditional organic solvents. The unusual catalytic and solvation properties of ionic liquids have attracted the biofuel and biomass communities because IL-pretreatment provides higher fermentable sugar yields than those obtained by acid- or alkali-pretreatment under similar severities. This research used lignin, a major by-product of the biofuel and pulping industries, as raw material for IL synthesis. The goal is to lower the cost of IL production, and enable a more "closed-loop" biorefinery. The lignin is oxidatively depolymerized, purified, and used to prepare a new class of renewable ILs. Biomass pretreatment was the target application for the lignin-derived ILs, while we continue to investigate additional applications within the growing IL market - process chemistry, biotechnology and materials recycling. When comparing our corn stover pretreatment data to recently published reports, we have shown comparable glucose and xylose yields by using neat and 10% aqueous solutions of lignin-derived ILs.

09 BIOMASS FUELS↗

Conversion of cellulose rich municipal solid waste blends using ionic liquids: feedstock convertibility and process scale-up

For this study, sixteen cellulose rich municipal solid waste (MSW) blends were developed and screened using an acid-assisted ionic liquid (IL) deconstruction process. Corn stover and switchgrass were chosen to represent herbaceous feedstocks; non-recyclable paper (NRP) and grass clippings (GC) collected from households were chosen as MSW candidates given their abundance in municipal waste streams. The most promising MSW blend: corn stover/non-recyclable paper (CS/NRP) at 80/20 ratio was identified in milliliter-scale screening based on the sugar yield, feedstock cost, and availability. A successful scale-up (600-fold) of the IL-acidolysis process on the identified CS/NRP blend has been achieved. The sugar and lignin streams were recovered and characterized. Mass and material energy flows of the optimized process were presented. Feedstock cost for MSW blends was also discussed. Results suggest the promising potential of using MSW as a feedstock blending agent for biorefineries while maintaining sufficient performance and low feedstock cost. The bench scale (6 L) study is an essential step in demonstrating the scalability of this IL technology.

09 BIOMASS FUELS↗

Structural basis of mutant-selectivity and drug-resistance related to CO-1686

Non-small-cell lung cancers (NSCLCs) caused by activating mutations in the kinase domain of epidermal growth factor receptor (EGFR) initially respond to first-generation reversible drugs gefitinib and erlotinib. However, clinical efficacy is limited due to the development of drug-resistance that in more than half of the cases are driven by the secondary T790M mutation. CO-1686 is one of the third generation irreversible inhibitors that inhibits EGFR activating mutants, including those with concurrent T790M, while avoiding the off-target toxicity owing to inhibition of wild-type EGFR in treating EGFR mutation-positive NSCLCs. Despite the remarkable success, the experimentally determined structure of this agent in complex with EGFR T790M remains unknown. In this study, we determined crystal structures of EGFR T790M or L858R mutants covalently bound by CO-1686. Based on these structural data, we can explain why CO-1686 irreversibly inhibits EGFR and selectively prefers T790M, which may help improving this or similar compounds, and explain why EGFR L718Q and L844V mutations incur resistance to this agent.

60 APPLIED LIFE SCIENCES↗